Uromodulin and α1-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases

Kidney and Blood Pressure Research

Volumn 35, Issue 5, 2012, Pages 314-325

  Navarro Muñoz, Maribel ^a   Ibernon, Meritxell ^a   Bonet, Josep ^a   Pérez, Vanessa ^a   Pastor, Mari Cruz ^a   Bayés, Beatriz ^a   Casado Vela, Juan ^b   Navarro, Maruja ^a   Ara, Jordi ^a   Espinal, Anna ^a   Fluvià, Lourdes ^a   Serra, Assumpta ^a   López, Dolores ^a   Romero, Ramón ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

1 Antitrypsin; Glomerular kidney disease; MALDI TOF MS analysis; Peptide profiling; Proteinuria; Urine proteomics; Uromodulin

Indexed keywords

ALPHA 1 ANTITRYPSIN; TAMM HORSFALL GLYCOPROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DEVICES; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEINURIA;

ADULT; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; BIOPSY; CREATININE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY; MALE; MIDDLE AGED; PLACENTAL LACTOGEN; PROTEIN ARRAY ANALYSIS; PROTEINURIA; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SEQUENCE ANALYSIS, PROTEIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UROMODULIN; YOUNG ADULT;

EID: 84857724000     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000335383     Document Type: Article

References (58)

1. Http://www.Usrds.Org.
2. Decramer S, Gonzalez de Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands JL, Schanstra JP: Urine in clinical proteomics. Mol Cell Proteomics 2008; 7: 1850-1862.
3. Pisitkun T, Johnstone R, Knepper MA: Discovery of urinary biomarkers. Mol Cell Proteomics 2006; 5: 1760-1771. (Pubitemid 44688186)
4. Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami MA, Jankowski J, Mischak H: Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 2007; 18: 1057-1071. (Pubitemid 46536892)
5. Julian BA, Suzuki H, Suzuki Y, Tomino Y, Spasovski G, Novak J: Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease. Proteomics Clin Appl 2009; 3: 1029-1043.
6. Thongboonkerd V: Biomarker discovery in glomerular diseases using urinary proteomics. Proteomics Clin Appl 2008; 2: 1413-1421.
7. Thongboonkerd V, Klein JB, Jevans AW, McLeish KR: Urinary proteomics and biomarker discovery for glomerular diseases. Contrib Nephrol 2004; 141: 292-307.
8. Thongboonkerd V: Renal and urinary proteomics. Proteomics Clin Appl 2008; 2: 947-949.
9. Niwa T: Biomarker discovery for kidney diseases by mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 870: 148-153.
10. Barratt J, Topham P: Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ 2007; 177: 361-368. (Pubitemid 47339533)
11. Casado-Vela J, del Pulgar TG, Cebrian A, Alvarez-Ayerza N, Lacal JC: Human urine proteomics: building a list of human urine cancer biomarkers. Expert Rev Proteomics 2011; 8: 347-360.
12. Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, Kang CS, Choi YJ: Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics 2006; 6: 1066-1076.
13. Janech MG, Raymond JR, Arthur JM: Proteomics in renal research. Am J Physiol Renal Physiol 2007; 292:F501-F512. (Pubitemid 46220516)
14. Pang JX, Ginanni N, Dongre AR, Hefta SA, Opitek GJ: Biomarker discovery in urine by proteomics. J Proteome Res 2002; 1: 161-169. (Pubitemid 36050265)
15. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del Boccio P, Pavone B, Perfumo F, Urbani A, Scolari F, Ghiggeri GM: Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 2006; 17: 3139-3148. (Pubitemid 44707774)
16. Hellin JL, Bech-Serra JJ, Moctezuma EL, Chocron S, Santin S, Madrid A, Vilalta R, Canals F, Torra R, Meseguer A, Nieto JL: Very low-molecular-mass fragments of albumin in the plasma of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 2009; 54: 871-880.
17. Magistroni R, Ligabue G, Lupo V, Furci L, Leonelli M, Manganelli L, Masellis M, Gatti V, Cavazzini F, Tizzanini W, Albertazzi A: Proteomic analysis of urine from proteinuric patients shows a proteolytic activity directed against albumin. Nephrol Dial Transplant 2009; 24: 1672-1681.
18. Ngai HH, Sit WH, Jiang PP, Xu RJ, Wan JM, Thongboonkerd V: Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery. J Proteome Res 2006; 5: 3038-3047. (Pubitemid 44749221)
19. Rocchetti MT, Centra M, Papale M, Bortone G, Palermo C, Centonze D, Ranieri E, Di Paolo S, Gesualdo L: Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics 2008; 8: 206-216.
20. Shui HA, Huang TH, Ka SM, Chen PH, Lin YF, Chen A: Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Nephrol Dial Transplant 2008; 23: 176-185.
21. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM: Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 2007; 18: 913-922. (Pubitemid 46434508)
22. Yokota H, Hiramoto M, Okada H, Kanno Y, Yuri M, Morita S, Naitou M, Ichikawa A, Katoh M, Suzuki H: Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria. Mol Cell Proteomics 2007; 6: 738-744. (Pubitemid 46630106)
23. Vanhoutte KJ, Laarakkers C, Marchiori E, Pickkers P, Wetzels JF, Willems JL, van den Heuvel LP, Russel FG, Masereeuw R: Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical tools. Nephrol Dial Transplant 2007; 22: 2932-2943. (Pubitemid 350093415)
24. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, Haller H, Mischak H: Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int 2005; 67: 2313-2320. (Pubitemid 41623391)
25. Julian BA, Wittke S, Haubitz M, Zurbig P, Schiffer E, McGuire BM, Wyatt RJ, Novak J: Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases. World J Urol 2007; 25: 467-476.
26. Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, Golovko I, Rupprecht HD, Haubitz M, Hecker H, Mischak H, Fliser D: Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 2004; 65: 2426-2434. (Pubitemid 38670029)
27. Xu BJ, Shyr Y, Liang X, Ma LJ, Donnert EM, Roberts JD, Zhang X, Kon V, Brown NJ, Caprioli RM, Fogo AB: Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol 2005; 16: 2967-2975. (Pubitemid 44743494)
28. Rossing K, Mischak H, Dakna M, Zurbig P, Novak J, Julian BA, Good DM, Coon JJ, Tarnow L, Rossing P: Urinary proteomics in diabetes and CKD. J Am Soc Nephrol 2008; 19: 1283-1290.
29. Papale M, Di Paolo S, Magistroni R, Lamacchia O, Di Palma AM, De Mattia A, Rocchetti MT, Furci L, Pasquali S, De Cosmo S, Cignarelli M, Gesualdo L: Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy. Diabetes Care 2010; 33: 2409-2415.
30. Lapolla A, Molin L, Seraglia R, Sechi A, Cosma C, Bonfante L, Chilelli NC, Ragazzi E, Traldi P: Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance. Eur J Mass Spectrom (Chichester) 2011; 17: 245-253.
31. Lapolla A, Seraglia R, Molin L, Williams K, Cosma C, Reitano R, Sechi A, Ragazzi E, Traldi P: Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study. J Mass Spectrom 2009; 44: 419-425.
32. Fiedler GM, Baumann S, Leichtle A, Oltmann A, Kase J, Thiery J, Ceglarek U: Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2007; 53: 421-428. (Pubitemid 46447938)
33. Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X: Identification of a uromodulin fragment for diagnosis of IgA nephropathy. Rapid Commun Mass Spectrom 2010; 24: 1971-1978.
34. Perez V, Navarro-Munoz M, Bayes B, Lauzurica R, Pastor MC, Troya M, Bonet J, Ibernon M, Navarro M, Serra A, Nunez A, Romero R: Effect of low doses of atorvastatin on the urinary peptide profile of kidney transplant patients. Transplant Proc 2009; 41: 2111-2114.
35. Perez V, Sanchez A, Bayes B, Navarro-Munoz M, Lauzurica R, Pastor MC, Romero R: Effect of paricalcitol on the urinary peptidome of kidney transplant patients. Transplant Proc 2010; 42: 2924-2927.
36. Perez V, Navarro-Munoz M, Mas S, Bayes B, Pastor MC, Martinez-Caceres E, Lauzurica R, Egido J, Romero R: Proteomic approach to the study of statin pleiotropy in kidney transplant patients. Pharmacology 2011; 87: 161-168.
37. Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, Tempst P: Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem 2004; 76: 1560-1570. (Pubitemid 38338398)
38. Casado-Vela J, Rodriguez-Suarez E, Iloro I, Ametzazurra A, Alkorta N, Garcia-Velasco JA, Matorras R, Prieto B, Gonzalez S, Nagore D, Simon L, Elortza F: Comprehensive proteomic analysis of human endometrial fluid aspirate. J Proteome Res 2009; 8: 4622-4632.
39. Casado-Vela J, Ruiz EJ, Nebreda AR, Casal JI: A combination of neutral loss and targeted product ion scanning with two enzymatic digestions facilitates the comprehensive mapping of phosphorylation sites. Proteomics 2007; 7: 2522-2529. (Pubitemid 47253812)
40. Craig R, Cortens JP, Beavis RC: The use of proteotypic peptide libraries for protein identification. Rapid Commun Mass Spectrom 2005; 19: 1844-1850. (Pubitemid 40886710)
41. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577. (Pubitemid 23118304)
42. Greenacre MJ, Blasius J: Multiple Correspondence Analysis and Related Methods. Boca Raton/London, Chapman & Hall/CRC, 2006.
43. Witzmann F, Clack J, Fultz C, Jarnot B: Two-dimensional electrophoretic mapping of hepatic and renal stress proteins. Electrophoresis 1995; 16: 451-459.
44. Marshall T, Williams K: Two-dimensional electrophoresis of human urinary proteins following concentration by dye precipitation. Electrophoresis 1996; 17: 1265-1272. (Pubitemid 26247155)
45. Rindler MJ, Naik SS, Li N, Hoops TC, Peraldi MN: Uromodulin (Tamm-Horsfall glycoprotein/uromucoid) is a phosphatidylinositol-linked membrane protein. J Biol Chem 1990; 265: 20784-20789. (Pubitemid 120014078)
46. Vyletal P, Bleyer AJ, Kmoch S: Uromodulin biology and pathophysiology - an update. Kidney Blood Press Res 2010; 33: 456-475.
47. Lhotta K: Uromodulin and chronic kidney disease. Kidney Blood Press Res 2010; 33: 393-398.
48. Rampoldi L, Scolari F, Amoroso A, Ghiggeri G, Devuyst O: The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. Kidney Int 2011; 80: 338-347.
49. Bachmann S, Metzger R, Bunnemann B: Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle's loop in rat kidney. Histochemistry 1990; 94: 517-523. (Pubitemid 20303247)
50. Bachmann S, Koeppen-Hagemann I, Kriz W: Ultrastructural localization of Tamm-Horsfall glycoprotein (THP) in rat kidney as revealed by protein A-gold immunocytochemistry. Histochemistry 1985; 83: 531-538. (Pubitemid 16176745)
51. Peach RJ, Day WA, Ellingsen PJ, McGiven AR: Ultrastructural localization of Tamm-Horsfall protein in human kidney using immunogold electron microscopy. Histochem J 1988; 20: 156-164.
52. Santambrogio S, Cattaneo A, Bernascone I, Schwend T, Jovine L, Bachi A, Rampoldi L: Urinary uromodulin carries an intact ZP domain generated by a conserved C-terminal proteolytic cleavage. Biochem Biophys Res Commun 2008; 370: 410-413.
53. Hession C, Decker JM, Sherblom AP, Kumar S, Yue CC, Mattaliano RJ, Tizard R, Kawashima E, Schmeissner U, Heletky S, et al: Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines. Science 1987; 237: 1479-1484. (Pubitemid 17134612)
54. Quintana LF, Campistol JM, Alcolea MP, Banon-Maneus E, Sol-Gonzalez A, Cutillas PR: Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics 2009; 8: 1658-1673.
55. Comunale MA, Rodemich-Betesh L, Hafner J, Wang M, Norton P, Di Bisceglie AM, Block T, Mehta A: Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma. PLoS One 2010; 5:e12419.
56. Machii R, Sakatume M, Kubota R, Kobayashi S, Gejyo F, Shiba K: Examination of the molecular diversity of alpha1 antitrypsin in urine: deficit of an alpha1 globulin fraction on cellulose acetate membrane electrophoresis. J Clin Lab Anal 2005; 19: 16-21. (Pubitemid 40170596)
57. Sharma K, Lee S, Han S, Francos B, McCue P, Wassell R, Shaw MA, RamachandraRao SP: Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005; 5: 2648-2655. (Pubitemid 40966492)
58. Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, Dominiczak A, Mischak H: Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 2007; 6: 4549-4555.